Our vision: individualize cancer medicine
IR Side Nav
Investor Contact Sylke Maas, Ph.D.
VP Investor Relations & Strategy
Send Email
+49 6131 9084-0
VP Investor Relations & Strategy
Send Email
+49 6131 9084-0
Media Contact Jasmina Alatovic
Director Global External Communications
Send Email
+49 6131 9084-0
Director Global External Communications
Send Email
+49 6131 9084-0
Overview
In this section you can find all materials related to our financial reporting
Latest Annual Report (20-F)
Latest SEC Filings
| Filing date | Description | Form | View |
|---|---|---|---|
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act |
6-K | View HTML | |
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act |
6-K | View HTML | |
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act |
6-K | View HTML |
